Endothelium-Derived 5-Methoxytryptophan Is a Circulating Anti-Inflammatory Molecule That Blocks Systemic Inflammation
RATIONALE:Systemic inflammation has emerged as a key pathophysiological process that induces multiorgan injury and causes serious human diseases. Endothelium is critical in maintaining cellular and inflammatory homeostasis, controlling systemic inflammation, and progression of inflammatory diseases....
Saved in:
Published in | Circulation research Vol. 119; no. 2; pp. 222 - 236 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Heart Association, Inc
08.07.2016
|
Subjects | |
Online Access | Get full text |
ISSN | 0009-7330 1524-4571 1524-4571 |
DOI | 10.1161/CIRCRESAHA.116.308559 |
Cover
Loading…
Abstract | RATIONALE:Systemic inflammation has emerged as a key pathophysiological process that induces multiorgan injury and causes serious human diseases. Endothelium is critical in maintaining cellular and inflammatory homeostasis, controlling systemic inflammation, and progression of inflammatory diseases. We postulated that endothelium produces and releases endogenous soluble factors to modulate inflammatory responses and protect against systemic inflammation.
OBJECTIVE:To identify endothelial cell–released soluble factors that protect against endothelial barrier dysfunction and systemic inflammation.
METHODS AND RESULTS:We found that conditioned medium of endothelial cells inhibited cyclooxgenase-2 and interleukin-6 expression in macrophages stimulated with lipopolysaccharide. Analysis of conditioned medium extracts by liquid chromatography–mass spectrometry showed the presence of 5-methoxytryptophan (5-MTP), but not other related tryptophan metabolites. Furthermore, endothelial cell–derived 5-MTP suppressed lipopolysaccharide-induced inflammatory responses and signaling in macrophages and endotoxemic lung tissues. Lipopolysaccharide suppressed 5-MTP level in endothelial cell-conditioned medium and reduced serum 5-MTP level in the murine sepsis model. Intraperitoneal injection of 5-MTP restored serum 5-MTP accompanied by the inhibition of lipopolysaccharide-induced endothelial leakage and suppression of lipopolysaccharide- or cecal ligation and puncture–mediated proinflammatory mediators overexpression. 5-MTP administration rescued lungs from lipopolysaccharide-induced damages and prevented sepsis-related mortality. Importantly, compared with healthy subjects, serum 5-MTP level in septic patients was decreased by 65%, indicating an important clinical relevance.
CONCLUSIONS:We conclude that 5-MTP belongs to a novel class of endothelium-derived protective molecules that defend against endothelial barrier dysfunction and excessive systemic inflammatory responses. |
---|---|
AbstractList | Systemic inflammation has emerged as a key pathophysiological process that induces multiorgan injury and causes serious human diseases. Endothelium is critical in maintaining cellular and inflammatory homeostasis, controlling systemic inflammation, and progression of inflammatory diseases. We postulated that endothelium produces and releases endogenous soluble factors to modulate inflammatory responses and protect against systemic inflammation.RATIONALESystemic inflammation has emerged as a key pathophysiological process that induces multiorgan injury and causes serious human diseases. Endothelium is critical in maintaining cellular and inflammatory homeostasis, controlling systemic inflammation, and progression of inflammatory diseases. We postulated that endothelium produces and releases endogenous soluble factors to modulate inflammatory responses and protect against systemic inflammation.To identify endothelial cell-released soluble factors that protect against endothelial barrier dysfunction and systemic inflammation.OBJECTIVETo identify endothelial cell-released soluble factors that protect against endothelial barrier dysfunction and systemic inflammation.We found that conditioned medium of endothelial cells inhibited cyclooxgenase-2 and interleukin-6 expression in macrophages stimulated with lipopolysaccharide. Analysis of conditioned medium extracts by liquid chromatography-mass spectrometry showed the presence of 5-methoxytryptophan (5-MTP), but not other related tryptophan metabolites. Furthermore, endothelial cell-derived 5-MTP suppressed lipopolysaccharide-induced inflammatory responses and signaling in macrophages and endotoxemic lung tissues. Lipopolysaccharide suppressed 5-MTP level in endothelial cell-conditioned medium and reduced serum 5-MTP level in the murine sepsis model. Intraperitoneal injection of 5-MTP restored serum 5-MTP accompanied by the inhibition of lipopolysaccharide-induced endothelial leakage and suppression of lipopolysaccharide- or cecal ligation and puncture-mediated proinflammatory mediators overexpression. 5-MTP administration rescued lungs from lipopolysaccharide-induced damages and prevented sepsis-related mortality. Importantly, compared with healthy subjects, serum 5-MTP level in septic patients was decreased by 65%, indicating an important clinical relevance.METHODS AND RESULTSWe found that conditioned medium of endothelial cells inhibited cyclooxgenase-2 and interleukin-6 expression in macrophages stimulated with lipopolysaccharide. Analysis of conditioned medium extracts by liquid chromatography-mass spectrometry showed the presence of 5-methoxytryptophan (5-MTP), but not other related tryptophan metabolites. Furthermore, endothelial cell-derived 5-MTP suppressed lipopolysaccharide-induced inflammatory responses and signaling in macrophages and endotoxemic lung tissues. Lipopolysaccharide suppressed 5-MTP level in endothelial cell-conditioned medium and reduced serum 5-MTP level in the murine sepsis model. Intraperitoneal injection of 5-MTP restored serum 5-MTP accompanied by the inhibition of lipopolysaccharide-induced endothelial leakage and suppression of lipopolysaccharide- or cecal ligation and puncture-mediated proinflammatory mediators overexpression. 5-MTP administration rescued lungs from lipopolysaccharide-induced damages and prevented sepsis-related mortality. Importantly, compared with healthy subjects, serum 5-MTP level in septic patients was decreased by 65%, indicating an important clinical relevance.We conclude that 5-MTP belongs to a novel class of endothelium-derived protective molecules that defend against endothelial barrier dysfunction and excessive systemic inflammatory responses.CONCLUSIONSWe conclude that 5-MTP belongs to a novel class of endothelium-derived protective molecules that defend against endothelial barrier dysfunction and excessive systemic inflammatory responses. RATIONALE:Systemic inflammation has emerged as a key pathophysiological process that induces multiorgan injury and causes serious human diseases. Endothelium is critical in maintaining cellular and inflammatory homeostasis, controlling systemic inflammation, and progression of inflammatory diseases. We postulated that endothelium produces and releases endogenous soluble factors to modulate inflammatory responses and protect against systemic inflammation. OBJECTIVE:To identify endothelial cell–released soluble factors that protect against endothelial barrier dysfunction and systemic inflammation. METHODS AND RESULTS:We found that conditioned medium of endothelial cells inhibited cyclooxgenase-2 and interleukin-6 expression in macrophages stimulated with lipopolysaccharide. Analysis of conditioned medium extracts by liquid chromatography–mass spectrometry showed the presence of 5-methoxytryptophan (5-MTP), but not other related tryptophan metabolites. Furthermore, endothelial cell–derived 5-MTP suppressed lipopolysaccharide-induced inflammatory responses and signaling in macrophages and endotoxemic lung tissues. Lipopolysaccharide suppressed 5-MTP level in endothelial cell-conditioned medium and reduced serum 5-MTP level in the murine sepsis model. Intraperitoneal injection of 5-MTP restored serum 5-MTP accompanied by the inhibition of lipopolysaccharide-induced endothelial leakage and suppression of lipopolysaccharide- or cecal ligation and puncture–mediated proinflammatory mediators overexpression. 5-MTP administration rescued lungs from lipopolysaccharide-induced damages and prevented sepsis-related mortality. Importantly, compared with healthy subjects, serum 5-MTP level in septic patients was decreased by 65%, indicating an important clinical relevance. CONCLUSIONS:We conclude that 5-MTP belongs to a novel class of endothelium-derived protective molecules that defend against endothelial barrier dysfunction and excessive systemic inflammatory responses. Systemic inflammation has emerged as a key pathophysiological process that induces multiorgan injury and causes serious human diseases. Endothelium is critical in maintaining cellular and inflammatory homeostasis, controlling systemic inflammation, and progression of inflammatory diseases. We postulated that endothelium produces and releases endogenous soluble factors to modulate inflammatory responses and protect against systemic inflammation. To identify endothelial cell-released soluble factors that protect against endothelial barrier dysfunction and systemic inflammation. We found that conditioned medium of endothelial cells inhibited cyclooxgenase-2 and interleukin-6 expression in macrophages stimulated with lipopolysaccharide. Analysis of conditioned medium extracts by liquid chromatography-mass spectrometry showed the presence of 5-methoxytryptophan (5-MTP), but not other related tryptophan metabolites. Furthermore, endothelial cell-derived 5-MTP suppressed lipopolysaccharide-induced inflammatory responses and signaling in macrophages and endotoxemic lung tissues. Lipopolysaccharide suppressed 5-MTP level in endothelial cell-conditioned medium and reduced serum 5-MTP level in the murine sepsis model. Intraperitoneal injection of 5-MTP restored serum 5-MTP accompanied by the inhibition of lipopolysaccharide-induced endothelial leakage and suppression of lipopolysaccharide- or cecal ligation and puncture-mediated proinflammatory mediators overexpression. 5-MTP administration rescued lungs from lipopolysaccharide-induced damages and prevented sepsis-related mortality. Importantly, compared with healthy subjects, serum 5-MTP level in septic patients was decreased by 65%, indicating an important clinical relevance. We conclude that 5-MTP belongs to a novel class of endothelium-derived protective molecules that defend against endothelial barrier dysfunction and excessive systemic inflammatory responses. |
Author | Yet, Shaw-Fang Yang, Ya-Sung Wang, Yi-Fu Lee, Guan-Lin Wu, Hsu-Feng Wu, Kenneth K. Hsu, Yu-Juei Kuo, Cheng-Chin Wu, Jing-Yiing |
AuthorAffiliation | From the Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan (Y.-F.W., H.-F.W., G.-L.L., J.-Y.W., S.-F.Y., K.K.W., C.-C.K.); Institute of Molecular Medicine, National Tsing Hua University, Hsinchu, Taiwan (Y.-F.W.); Division of Nephrology (Y.-J.H.), Division of Infectious Diseases and Tropical Medicine (Y.-S.Y.), Department of Medicine, Tri-Service General Hospital (Y.-J.H., Y.-S.Y.), and Graduate Institutes of Life Sciences and Biochemistry (Y.-J.H., G.-L.L., Y.-S.Y., C.-C.K.), National Defense Medical Center, Taipei, Taiwan; Metabolomic Research Center, China Medical University Hospital (S.-F.Y., K.K.W., C.-C.K.) and Graduate Institute of Basic Medical Science (S.-F.Y., K.K.W., C.-C.K.), China Medical University, Taichung, Taiwan; and Department of Medicine, University of Texas, Houston (K.K.W.) |
AuthorAffiliation_xml | – name: From the Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan (Y.-F.W., H.-F.W., G.-L.L., J.-Y.W., S.-F.Y., K.K.W., C.-C.K.); Institute of Molecular Medicine, National Tsing Hua University, Hsinchu, Taiwan (Y.-F.W.); Division of Nephrology (Y.-J.H.), Division of Infectious Diseases and Tropical Medicine (Y.-S.Y.), Department of Medicine, Tri-Service General Hospital (Y.-J.H., Y.-S.Y.), and Graduate Institutes of Life Sciences and Biochemistry (Y.-J.H., G.-L.L., Y.-S.Y., C.-C.K.), National Defense Medical Center, Taipei, Taiwan; Metabolomic Research Center, China Medical University Hospital (S.-F.Y., K.K.W., C.-C.K.) and Graduate Institute of Basic Medical Science (S.-F.Y., K.K.W., C.-C.K.), China Medical University, Taichung, Taiwan; and Department of Medicine, University of Texas, Houston (K.K.W.) |
Author_xml | – sequence: 1 givenname: Yi-Fu surname: Wang fullname: Wang, Yi-Fu organization: From the Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan (Y.-F.W., H.-F.W., G.-L.L., J.-Y.W., S.-F.Y., K.K.W., C.-C.K.); Institute of Molecular Medicine, National Tsing Hua University, Hsinchu, Taiwan (Y.-F.W.); Division of Nephrology (Y.-J.H.), Division of Infectious Diseases and Tropical Medicine (Y.-S.Y.), Department of Medicine, Tri-Service General Hospital (Y.-J.H., Y.-S.Y.), and Graduate Institutes of Life Sciences and Biochemistry (Y.-J.H., G.-L.L., Y.-S.Y., C.-C.K.), National Defense Medical Center, Taipei, Taiwan; Metabolomic Research Center, China Medical University Hospital (S.-F.Y., K.K.W., C.-C.K.) and Graduate Institute of Basic Medical Science (S.-F.Y., K.K.W., C.-C.K.), China Medical University, Taichung, Taiwan; and Department of Medicine, University of Texas, Houston (K.K.W.) – sequence: 2 givenname: Yu-Juei surname: Hsu fullname: Hsu, Yu-Juei – sequence: 3 givenname: Hsu-Feng surname: Wu fullname: Wu, Hsu-Feng – sequence: 4 givenname: Guan-Lin surname: Lee fullname: Lee, Guan-Lin – sequence: 5 givenname: Ya-Sung surname: Yang fullname: Yang, Ya-Sung – sequence: 6 givenname: Jing-Yiing surname: Wu fullname: Wu, Jing-Yiing – sequence: 7 givenname: Shaw-Fang surname: Yet fullname: Yet, Shaw-Fang – sequence: 8 givenname: Kenneth surname: Wu middlename: K. fullname: Wu, Kenneth K. – sequence: 9 givenname: Cheng-Chin surname: Kuo fullname: Kuo, Cheng-Chin |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27151398$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU1P3DAQhi1EBcvCT6DysZdQO47zoZ626QIrgSrtwjlynEnj4thb2ynk35PtUir1sidr7OexZuY9Q8fGGkDokpIrSlP6uVyty_Vys7hd7OorRnLOiyM0ozxOooRn9BjNCCFFlDFGTtGZ9z8JoQmLixN0GmeUU1bkMzQsTWNDB1oNffQNnPoNDebRPYTOvozBjdtgt50weOWxwKVyctAiKPMDL0xQ0cq0WvS9CNaN-N5qmJ4BP3Qi4K_ayiePN6MP0CuJ31FlzTn60Art4eLtnKPH6-VDeRvdfb9ZlYu7SCYknVpPJTRZnIs6qVvRxi0FLvLplhRNS2WSMZjApJY85m3NGp6nkuXT0LFkRIiczdGn_b9bZ38N4EPVKy9Ba2HADr6iOYmzhFKeTujHN3Soe2iqrVO9cGP1d1UTwPeAdNZ7B-07Qkm1i6T6F8murvaRTN6X_zypwp8tBCeUPmgXe_vZ6gDOP-nhGVzVgdChO-C-AqUHpjM |
CitedBy_id | crossref_primary_10_1186_s12929_020_00671_w crossref_primary_10_18632_aging_102350 crossref_primary_10_1074_jbc_RA117_000597 crossref_primary_10_1186_s12896_024_00890_1 crossref_primary_10_3390_ijms22094490 crossref_primary_10_3390_ijms17091394 crossref_primary_10_1016_j_yjmcc_2021_05_014 crossref_primary_10_1097_MOH_0000000000000848 crossref_primary_10_1038_s41598_017_11077_4 crossref_primary_10_1039_D3FO01831H crossref_primary_10_1038_s41598_018_25015_5 crossref_primary_10_1007_s00726_020_02878_5 crossref_primary_10_1007_s10753_016_0464_6 crossref_primary_10_1161_CIRCRESAHA_116_309122 crossref_primary_10_1016_j_molcel_2019_10_023 crossref_primary_10_1097_IMNA_D_24_00019 crossref_primary_10_1016_j_lfs_2020_118399 crossref_primary_10_1186_s12929_021_00771_1 crossref_primary_10_5847_wjem_j_1920_8642_2023_019 crossref_primary_10_1007_s12265_024_10518_6 crossref_primary_10_3390_ijms22020697 crossref_primary_10_3389_fimmu_2023_1300378 crossref_primary_10_1080_0886022X_2024_2409346 crossref_primary_10_3389_fped_2022_828968 crossref_primary_10_1161_RES_0000000000000152 crossref_primary_10_1186_s13765_022_00705_x crossref_primary_10_1016_j_jmii_2018_12_003 crossref_primary_10_3390_ijms20246115 crossref_primary_10_1016_j_freeradbiomed_2022_06_235 crossref_primary_10_30683_1927_7229_2021_10_01 crossref_primary_10_1016_j_heliyon_2023_e19501 crossref_primary_10_1016_j_freeradbiomed_2021_01_040 crossref_primary_10_3389_fimmu_2023_1072810 crossref_primary_10_1155_2017_8314276 crossref_primary_10_1177_2040622320962648 crossref_primary_10_1038_s41522_024_00631_4 crossref_primary_10_3390_cancers13215311 crossref_primary_10_1159_000543275 crossref_primary_10_1021_acscombsci_9b00050 crossref_primary_10_1038_s41467_019_09329_0 crossref_primary_10_1016_j_intimp_2020_106988 crossref_primary_10_1016_j_jchromb_2018_01_008 crossref_primary_10_1007_s12272_016_0809_6 crossref_primary_10_3390_ijms23147548 crossref_primary_10_1161_JAHA_123_029785 crossref_primary_10_2337_db22_0095 crossref_primary_10_1016_j_ijcard_2016_12_154 crossref_primary_10_1007_s00011_023_01769_1 crossref_primary_10_1039_D4FO02039A crossref_primary_10_1080_15384101_2021_1897241 crossref_primary_10_2147_JIR_S474040 crossref_primary_10_1186_s13071_023_05881_3 crossref_primary_10_1016_j_ijcard_2016_12_151 crossref_primary_10_1371_journal_pone_0182707 crossref_primary_10_1002_tox_22749 crossref_primary_10_3389_fphar_2021_759199 crossref_primary_10_1016_j_heliyon_2024_e33309 crossref_primary_10_1016_j_chemosphere_2024_142615 crossref_primary_10_1038_s41598_020_63313_z crossref_primary_10_3748_wjg_v29_i47_6148 crossref_primary_10_1155_2024_1484806 crossref_primary_10_1161_ATVBAHA_118_311874 crossref_primary_10_1210_clinem_dgae593 crossref_primary_10_1007_s00018_017_2504_2 crossref_primary_10_1038_s41598_024_82047_w |
Cites_doi | 10.1097/MPA.0000000000000270 10.1161/CIRCULATIONAHA.106.652859 10.1016/j.abb.2013.12.014 10.1074/jbc.R000025200 10.1189/jlb.0607373 10.1016/j.bbagrm.2013.04.007 10.1038/ni.2785 10.1046/j.1440-1711.2003.t01-1-01177.x 10.1186/2110-5820-1-17 10.1016/j.it.2012.05.002 10.1016/j.prostaglandins.2015.04.006 10.1038/nri2402 10.1182/blood-2005-09-3691 10.1016/j.jss.2008.04.030 10.1189/jlb.0105017 10.1074/jbc.M111.295113 10.1016/j.ajpath.2012.11.022 10.1159/000430785 10.1016/S0006-2952(03)00556-2 10.1038/nm0503-517 10.1124/pr.109.001073 10.1016/j.tem.2010.08.007 10.1038/nrd1854 10.1074/jbc.M209286200 10.1161/01.ATV.0000157899.35660.61 10.4049/jimmunol.171.12.6581 10.1016/j.thromres.2011.10.013 10.1073/pnas.1209919109 10.1155/2010/641865 10.1097/CCM.0b013e31828a44ed 10.4049/jimmunol.178.10.6100 10.4049/jimmunol.179.10.7101 10.1093/emboj/cdg139 10.1371/journal.pone.0088507 10.1161/01.cir.0000018127.10968.34 10.1084/jem.20101629 10.1074/jbc.275.9.6259 10.1038/nm.2092 10.1161/ATVBAHA.112.300302 10.1016/S0065-2776(08)60740-3 10.1038/nrd3793 10.1097/01.CCM.0000050454.01978.3B 10.1152/ajpregu.00858.2009 10.1111/j.1600-065X.2011.01088.x 10.1128/MCB.26.3.789-809.2006 10.1007/s10753-007-9027-1 |
ContentType | Journal Article |
Copyright | 2016 American Heart Association, Inc. |
Copyright_xml | – notice: 2016 American Heart Association, Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1161/CIRCRESAHA.116.308559 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4571 |
EndPage | 236 |
ExternalDocumentID | 27151398 10_1161_CIRCRESAHA_116_308559 10.1161/CIRCRESAHA.116.308559 |
Genre | Journal Article |
GroupedDBID | --- -~X .-D .3C .Z2 01R 0R~ 18M 1J1 29B 2WC 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAMOA AAMTA AAQKA AARTV AASCR AASOK AAXQO ABASU ABBUW ABDIG ABJNI ABOCM ABPXF ABQRW ABVCZ ABXVJ ABZAD ABZZY ACCJW ACDDN ACEWG ACGFO ACGFS ACILI ACLDA ACNWC ACPRK ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADGGA ADHPY AE3 AE6 AEETU AENEX AFBFQ AFDTB AFUWQ AGINI AHMBA AHOMT AHQNM AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BAWUL BOYCO BQLVK C45 CS3 DIK DIWNM DU5 E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FRP GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JK3 JK8 K8S KD2 KMI KQ8 L-C L7B N9A N~7 N~B O9- OAG OAH OB2 OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OWW OWY OXXIT P2P PQQKQ RAH RIG RLZ S4R S4S T8P TEORI TR2 TSPGW UPT V2I VVN W3M W8F WH7 WOQ WOW X3V X3W YFH YOC ZFV ZZMQN AAYXX ADGHP CITATION CGR CUY CVF ECM EIF NPM 7X8 ADSXY |
ID | FETCH-LOGICAL-c4069-76ced728ab4bfaf2f1e5a876c09df1c473ec404bc525fb3d586c380092c30aa83 |
ISSN | 0009-7330 1524-4571 |
IngestDate | Fri Sep 05 07:26:00 EDT 2025 Mon Jul 21 06:06:24 EDT 2025 Thu Apr 24 23:04:17 EDT 2025 Tue Jul 01 04:27:47 EDT 2025 Fri May 16 03:43:19 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | 5-methoxytryptophan inflammation sepsis capillary permeability shock |
Language | English |
License | 2016 American Heart Association, Inc. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4069-76ced728ab4bfaf2f1e5a876c09df1c473ec404bc525fb3d586c380092c30aa83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ahajournals.org/doi/pdf/10.1161/CIRCRESAHA.116.308559 |
PMID | 27151398 |
PQID | 1802741156 |
PQPubID | 23479 |
PageCount | 15 |
ParticipantIDs | proquest_miscellaneous_1802741156 pubmed_primary_27151398 crossref_primary_10_1161_CIRCRESAHA_116_308559 crossref_citationtrail_10_1161_CIRCRESAHA_116_308559 wolterskluwer_health_10_1161_CIRCRESAHA_116_308559 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-July-8 2016-07-08 2016-Jul-08 20160708 |
PublicationDateYYYYMMDD | 2016-07-08 |
PublicationDate_xml | – month: 07 year: 2016 text: 2016-July-8 day: 08 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Circulation research |
PublicationTitleAlternate | Circ Res |
PublicationYear | 2016 |
Publisher | American Heart Association, Inc |
Publisher_xml | – name: American Heart Association, Inc |
References | e_1_3_5_28_2 e_1_3_5_27_2 e_1_3_5_26_2 e_1_3_5_25_2 e_1_3_5_24_2 e_1_3_5_23_2 e_1_3_5_22_2 e_1_3_5_21_2 e_1_3_5_43_2 e_1_3_5_44_2 e_1_3_5_45_2 e_1_3_5_46_2 e_1_3_5_47_2 e_1_3_5_29_2 e_1_3_5_2_2 e_1_3_5_40_2 e_1_3_5_41_2 e_1_3_5_42_2 e_1_3_5_8_2 e_1_3_5_20_2 e_1_3_5_7_2 e_1_3_5_9_2 e_1_3_5_4_2 e_1_3_5_3_2 e_1_3_5_6_2 e_1_3_5_5_2 e_1_3_5_17_2 e_1_3_5_39_2 e_1_3_5_16_2 e_1_3_5_38_2 e_1_3_5_15_2 e_1_3_5_37_2 e_1_3_5_14_2 e_1_3_5_36_2 e_1_3_5_12_2 e_1_3_5_35_2 e_1_3_5_13_2 e_1_3_5_34_2 e_1_3_5_10_2 e_1_3_5_33_2 e_1_3_5_11_2 e_1_3_5_32_2 e_1_3_5_19_2 e_1_3_5_18_2 e_1_3_5_31_2 e_1_3_5_30_2 27390326 - Circ Res. 2016 Jul 8;119(2):178-80 27587414 - Circ Res. 2016 Sep 2;119(6):e108 |
References_xml | – ident: e_1_3_5_25_2 doi: 10.1097/MPA.0000000000000270 – ident: e_1_3_5_22_2 doi: 10.1161/CIRCULATIONAHA.106.652859 – ident: e_1_3_5_28_2 doi: 10.1016/j.abb.2013.12.014 – ident: e_1_3_5_31_2 doi: 10.1074/jbc.R000025200 – ident: e_1_3_5_2_2 doi: 10.1189/jlb.0607373 – ident: e_1_3_5_30_2 doi: 10.1016/j.bbagrm.2013.04.007 – ident: e_1_3_5_35_2 doi: 10.1038/ni.2785 – ident: e_1_3_5_44_2 doi: 10.1046/j.1440-1711.2003.t01-1-01177.x – ident: e_1_3_5_4_2 doi: 10.1186/2110-5820-1-17 – ident: e_1_3_5_11_2 doi: 10.1016/j.it.2012.05.002 – ident: e_1_3_5_14_2 doi: 10.1016/j.prostaglandins.2015.04.006 – ident: e_1_3_5_8_2 doi: 10.1038/nri2402 – ident: e_1_3_5_24_2 doi: 10.1182/blood-2005-09-3691 – ident: e_1_3_5_39_2 doi: 10.1016/j.jss.2008.04.030 – ident: e_1_3_5_9_2 doi: 10.1189/jlb.0105017 – ident: e_1_3_5_18_2 doi: 10.1074/jbc.M111.295113 – ident: e_1_3_5_23_2 doi: 10.1016/j.ajpath.2012.11.022 – ident: e_1_3_5_20_2 doi: 10.1159/000430785 – ident: e_1_3_5_46_2 doi: 10.1016/S0006-2952(03)00556-2 – ident: e_1_3_5_3_2 doi: 10.1038/nm0503-517 – ident: e_1_3_5_10_2 doi: 10.1124/pr.109.001073 – ident: e_1_3_5_41_2 doi: 10.1016/j.tem.2010.08.007 – ident: e_1_3_5_6_2 doi: 10.1038/nrd1854 – ident: e_1_3_5_27_2 doi: 10.1074/jbc.M209286200 – ident: e_1_3_5_38_2 doi: 10.1161/01.ATV.0000157899.35660.61 – ident: e_1_3_5_26_2 doi: 10.4049/jimmunol.171.12.6581 – ident: e_1_3_5_5_2 doi: 10.1016/j.thromres.2011.10.013 – ident: e_1_3_5_15_2 doi: 10.1073/pnas.1209919109 – ident: e_1_3_5_13_2 doi: 10.1155/2010/641865 – ident: e_1_3_5_40_2 doi: 10.1097/CCM.0b013e31828a44ed – ident: e_1_3_5_21_2 doi: 10.4049/jimmunol.178.10.6100 – ident: e_1_3_5_42_2 doi: 10.4049/jimmunol.179.10.7101 – ident: e_1_3_5_43_2 doi: 10.1093/emboj/cdg139 – ident: e_1_3_5_16_2 doi: 10.1371/journal.pone.0088507 – ident: e_1_3_5_29_2 doi: 10.1161/01.cir.0000018127.10968.34 – ident: e_1_3_5_47_2 doi: 10.1084/jem.20101629 – ident: e_1_3_5_37_2 doi: 10.1074/jbc.275.9.6259 – ident: e_1_3_5_12_2 doi: 10.1038/nm.2092 – ident: e_1_3_5_19_2 doi: 10.1161/ATVBAHA.112.300302 – ident: e_1_3_5_36_2 doi: 10.1016/S0065-2776(08)60740-3 – ident: e_1_3_5_45_2 doi: 10.1038/nrd3793 – ident: e_1_3_5_17_2 doi: 10.1097/01.CCM.0000050454.01978.3B – ident: e_1_3_5_33_2 doi: 10.1152/ajpregu.00858.2009 – ident: e_1_3_5_34_2 doi: 10.1111/j.1600-065X.2011.01088.x – ident: e_1_3_5_32_2 doi: 10.1128/MCB.26.3.789-809.2006 – ident: e_1_3_5_7_2 doi: 10.1007/s10753-007-9027-1 – reference: 27587414 - Circ Res. 2016 Sep 2;119(6):e108 – reference: 27390326 - Circ Res. 2016 Jul 8;119(2):178-80 |
SSID | ssj0014329 |
Score | 2.457589 |
Snippet | RATIONALE:Systemic inflammation has emerged as a key pathophysiological process that induces multiorgan injury and causes serious human diseases. Endothelium... Systemic inflammation has emerged as a key pathophysiological process that induces multiorgan injury and causes serious human diseases. Endothelium is critical... |
SourceID | proquest pubmed crossref wolterskluwer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 222 |
SubjectTerms | Aged Aged, 80 and over Animals Anti-Inflammatory Agents - blood Endothelium, Vascular - metabolism Endotoxemia - blood Endotoxemia - prevention & control Female Human Umbilical Vein Endothelial Cells - metabolism Humans Inflammation - blood Inflammation - prevention & control Male Mice Mice, Inbred C57BL Middle Aged Tryptophan - analogs & derivatives Tryptophan - blood |
Title | Endothelium-Derived 5-Methoxytryptophan Is a Circulating Anti-Inflammatory Molecule That Blocks Systemic Inflammation |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27151398 https://www.proquest.com/docview/1802741156 |
Volume | 119 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3rb9MwELfKkBAIId6Ul4zEt8qjifPqx6psagdFAnXS-BTZjj2ibenUJMD4g_g7uUucNFMrBvsStY7tRLmfz3fnexDy1kv8SHPpMpMEioH-ZZjAdeWEQga-UdyVaBqYfwqmh97BkX_U6_3ueC2VhdxVv7bGlVyHqtAGdMUo2f-gbDspNMBvoC9cgcJw_Sca72UJBlCdpuUZew8P_A7So8_mWBT650WxujjHrAGwgGf5QAwm6UpVtbrQDpIVKZtlBuBwVh-zz-syuXqw-IYmA9jiTnKbzjxVg7ZrQ8Umt0Ez5xKjYjqGscpEX7ORrynbL1v05GXVVrKDUqdt16oR7jH4vMdNq_URAhBn7KNNEG7tE05Q-bJGa0Q1B09TeIeiC7oNZ0-U91jI7TlNw50tR007WrLltXVAs9223TqPyuaOEOCOMJl9mQCix9Mxtuxy9M4brbfA1jHxihE3yE0X1BEsEfLh8_q0yuPuqKnYh-9vI8Vgondbp7ksA20oNnfI3R9L9JXIT6pQiY7As7hP7llNhY5r2D0gPZ09JLfm1hfjESm3oI9uQR-d5VTQDvroBvpogz6K6KM1-miDPtpF32NyuL-3mEyZLeLBFAZVszBQOgndSEhPGmFc42hfwBashqPEOMoLuYaOnlS-6xvJgXUEikeYCkzxoRARf0J2smWmnxEqNB9KbXzJtecNRSC1l3iVCu47iTZun3jNZ42VzXCPhVZO40rTDZx4TQ38H9fU6JPddth5neLlqgFvGprFwIzxhE1kelnmMaZTBBHd8YM-eVoTs53SDUG45qOoT9xL1I3rgOe_P_L5dQa9ILfXC_Il2SlWpX4FInQhX1f4_QNYY8QQ |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Endothelium-Derived+5-Methoxytryptophan+Is+a+Circulating+Anti-Inflammatory+Molecule+That+Blocks+Systemic+Inflammation&rft.jtitle=Circulation+research&rft.au=Wang%2C+Yi-Fu&rft.au=Hsu%2C+Yu-Juei&rft.au=Wu%2C+Hsu-Feng&rft.au=Lee%2C+Guan-Lin&rft.date=2016-07-08&rft.pub=American+Heart+Association%2C+Inc&rft.issn=0009-7330&rft.volume=119&rft.issue=2&rft.spage=222&rft.epage=236&rft_id=info:doi/10.1161%2FCIRCRESAHA.116.308559&rft.externalDocID=10.1161%2FCIRCRESAHA.116.308559 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7330&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7330&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7330&client=summon |